57 related articles for article (PubMed ID: 24166670)
1. Unexpected interaction between CYP3A4 and BI 11634: is BI 11634 interacting with CYP3A4 similar to nifedipine?
Mathur A; Tweedie DJ; Maw HH; Li Y
Drug Metabol Drug Interact; 2013; 28(4):239-46. PubMed ID: 24166670
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
Patki KC; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Jul; 31(7):938-44. PubMed ID: 12814972
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.
Zhao XP; Zhong J; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2007 Jan; 28(1):118-24. PubMed ID: 17184591
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine.
Kudo S; Okumura H; Miyamoto G; Ishizaki T
Drug Metab Dispos; 1999 Feb; 27(2):303-8. PubMed ID: 9929520
[TBL] [Abstract][Full Text] [Related]
8. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation.
Zhu Y; Wang F; Li Q; Zhu M; Du A; Tang W; Chen W
Drug Metab Dispos; 2014 Feb; 42(2):245-9. PubMed ID: 24301608
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
10. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
Ma B; Prueksaritanont T; Lin JH
Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
12. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.
Chen Y; Liu L; Nguyen K; Fretland AJ
Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079
[TBL] [Abstract][Full Text] [Related]
13. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
Niwa T; Shiraga T; Hashimoto T; Kagayama A
Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
[TBL] [Abstract][Full Text] [Related]
14. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
Ekström G; Gunnarsson UB
Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
[TBL] [Abstract][Full Text] [Related]
15. Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation.
Foti RS; Rock DA; Wienkers LC; Wahlstrom JL
Drug Metab Dispos; 2010 Jun; 38(6):981-7. PubMed ID: 20203109
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the inhibitory and induction potential of YM758, a novel If channel inhibitor, for human P450-mediated metabolism.
Umehara KI; Susaki Y; Van Teylingen RH; Neat JN; Ndikum-Moffor F; Noguchi K; Usui T; Parkinson A; Kamimura H
Eur J Drug Metab Pharmacokinet; 2008; 33(4):211-23. PubMed ID: 19230594
[TBL] [Abstract][Full Text] [Related]
17. Interaction potential of Trigonella foenum graceum through cytochrome P450 mediated inhibition.
Ahmmed SM; Mukherjee PK; Bahadur S; Kar A; Mukherjee K; Karmakar S; Bandyopadhyay A
Indian J Pharmacol; 2015; 47(5):530-4. PubMed ID: 26600643
[TBL] [Abstract][Full Text] [Related]
18. CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions.
Galetin A; Ito K; Hallifax D; Houston JB
J Pharmacol Exp Ther; 2005 Jul; 314(1):180-90. PubMed ID: 15784650
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4.
Koley AP; Robinson RC; Markowitz A; Friedman FK
Biochem Pharmacol; 1997 Feb; 53(4):455-60. PubMed ID: 9105395
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of bencycloquidium bromide and its inhibitory effects on human P450 isoenzymes: implication of CYP2D6, CYP2C19 and CYP3A4/5.
Agbokponto JE; Zhang L; Hu L; Feng H; Ding L
Eur J Drug Metab Pharmacokinet; 2016 Feb; 41(1):69-77. PubMed ID: 25425116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
